真菌性假体周围关节感染治疗策略比较:系统综述与网状Meta分析
该系统综述与网状Meta分析纳入17项研究共691例真菌性假体周围关节感染(FPJI)病例(髋335例、膝356例),比较不同治疗策略的感染清除效果。结果显示DAIR的治疗成功 odds 显著低于一期翻修(OR=0.32,95%CI 0.11–0.90)和二期翻修(OR=0.40,95%CI 0.24–0.69),其余策略间无显著差异,DAIR应考虑为FPJI的禁忌。
要点
- DAIR治疗FPJI的成功 odds 显著低于一期翻修(OR=0.32)和二期翻修(OR=0.40)。
- 三期翻修、假体取出、关节融合、截肢及抗真菌抑制治疗间无显著差异。
- 无明确证据表明关节类型(膝或髋)改变治疗效果。
核心结论
- 大多数手术治疗策略之间无显著差异,但DAIR与显著更低的治疗成功相关,应考虑为FPJI的禁忌。
研究设计与样本
- 系统综述与网状Meta分析,检索4个数据库至2025年9月,纳入报告超过10例的队列研究和病例系列,共17篇文章691例FPJI(髋335例、膝356例)。
- 使用ROBINS-I评估纳入研究质量,采用频率学框架随机效应模型进行网状Meta分析,效应量为比值比(OR)及95%置信区间(CI)。
主要发现
- DAIR的治疗成功 odds 较一期翻修低68%(OR=0.32,95%CI 0.11–0.90),较二期翻修低60%(OR=0.40,95%CI 0.24–0.69)。
- 三期翻修、确定性假体取出、关节融合、截肢及抗真菌抑制治疗等其他比较均无统计学显著差异。
- 无明确证据表明关节类型(膝或髋)修饰治疗效果。
关键数值与推荐
- DAIR vs 一期翻修:OR=0.32(95%CI 0.11–0.90)。
- DAIR vs 二期翻修:OR=0.40(95%CI 0.24–0.69)。
临床怎么用
- FPJI治疗中应避免将DAIR作为感染清除策略,优先考虑一期或二期翻修等手术方案。
局限性
- 纳入研究为非随机对照的队列研究和病例系列,证据异质性大且FPJI本身罕见,可能影响比较结果的稳健性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fungal periprosthetic joint infection (FPJI) is extremely rare, but has devastating outcomes and lower treatment success rates than bacterial periprosthetic joint infection. However, optimal management remains unclear due to limited and heterogeneous evidence. We aimed to examine the comparative effects of different interventions for infection eradication using a network meta-analysis approach. METHODS: There were four databases searched from their inception to September 2025. Cohort studies and case series reporting more than 10 cases were included. The quality of the included studies was assessed using Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I). A total of 691 FPJI cases (including 335 hips and 356 knees) from 17 articles were included. Network meta-analysis was performed using a random-effects model in a frequentist framework. The effect was measured using odds ratios (OR) with 95% confidence intervals (CI). RESULTS: The odds of treatment success with DAIR (debridement, antibiotic, and implant retention) were 68% lower than with one-stage revision (OR = 0.32, 95% CI = 0.11 to 0.90) and 60% lower than with two-stage revision (OR = 0.40, 95% CI = 0.24 to 0.69). There were no statistically significant differences observed in other treatment comparisons (three-stage revision, definite implant resection, arthrodesis, amputation, and antifungal suppression). There was no clear evidence that joint type (knee or hip) modified the treatment effect. CONCLUSIONS: There were no significant differences observed between most surgical treatment strategies for FPJI. However, DAIR was associated with significantly lower treatment success and should be considered as a contraindication in FPJI.
引用
- Rattanaprichavej P, Laoruengthana A, Chinwatanawongwan B, et al. Comparative Effects of Treatment Strategies for Fungal Periprosthetic Joint Infection: A Systematic Review and Network Meta-Analysis. J Arthroplasty. 2026. PMID: 42767532. doi:10.1016/j.arth.2026.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。